- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT03694717
Time Course Evolution of Cardiac Output (TCCO)
Time Course Evolution of Cardiac Output in Critically Ill Patients After a Fluid Expansion
Fluid expansion is the first therapeutic option in patients presenting acute circulatory failure but the duration of its hemodynamic effects (persistency and time of maximal increase in cardiac output) is unknown.
This study is seeking to describe in critically ill patients, the time course evolution of cardiac output over a 2-hours period after a fluid expansion.
The objectives are:
- to identify patterns of fluid responsiveness
- to determine the time when the maximal increase in cardiac output occurs during and a after fluid expansion
- to compare patients' characteristics between patterns
Patients with acute circulatory failure will be recruited as soon as a fluid expansion will be decided by the physician in charge and the effects of fluid expansion on hemodynamic indices (cardiac output, arterial pressure) will be continuously recorded through a transpulmonary thermodilution device over a 2-hours period.
No changes in ventilatory settings nor vasopressors or sedatives will be allowed during the study.
Patients will be categorized into patterns according to the changes in cardiac output after fluid expansion and their characteristics will be compared.
Studie Overzicht
Toestand
Conditie
Interventie / Behandeling
Gedetailleerde beschrijving
The study will be conducted in four medico-surgical ICUs in France between April 2016 and April 2018.
Since fluid challenge and invasive monitoring by thermodilution device is standard of care for septic shock management, the institutional review board waived patient consent. All patients and/or their next of kind will receive written information.
Eligible patients will have to present an acute circulatory failure for whom the physician in charge will decide to start a fluid expansion.
Hemodynamic variables will be obtained through transpulmonary thermodilution and pulse contour analysis (PICCO2 device, Pulsion Germany).
Fluid expansion will consist in the infusion of 500 ml of saline through a central venous catheter in a standardized 10-minutes period. The duration of infusion will be controlled by an airbag pressurized at 300 mmHg.
Fluid responsiveness will be defined by an increase in cardiac output over 15-per-cent from baseline (before fluid expansion).
Study design:
At time of decision to make the fluid expansion, a calibration of the PICCO2 device will be performed and a first set of hemodynamic measurements will be collected (cardiac output, cardiac function index, extravascular lung water, permeability vascular pulmonary index, global end diastolic volume, arterial pressure, heart rate).
Then, fluid expansion will be administrated in less than 10 minutes. From the start of fluid expansion to the end of the two-hours period ot time, pulse contour cardiac output and arterial pressure will be continuously recorded.
During the whole two hours period, no change in vasopressor dosage nor mechanical ventilation settings will be allowed.
In case of hemodynamic instability, defined by a mean arterial pressure under 65mmHg, a new fluid expansion could be realized. In this last case, the protocol will start again from the beginning.
Studietype
Inschrijving (Werkelijk)
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Bemonsteringsmethode
Studie Bevolking
Beschrijving
Inclusion Criteria:
- acute circulatory failure (infusion of norepinephrine)
- invasive mechanical ventilation through an endotracheal tube
- decision of fluid expansion
Non inclusion Criteria:
- extracorporeal membranous oxygenation (ECMO)
- active bleeding
- continuous renal replacement therapy with weight loss
- administration of diuretics within the past six hours
- decision of therapeutic limitation,
- age under eighteen years
Exclusion criteria:
- hemodynamic instability after fluid expansion (mean arterial pressure < 65mmHg)
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Observatiemodellen: Cohort
- Tijdsperspectieven: Prospectief
Cohorten en interventies
Groep / Cohort |
Interventie / Behandeling |
---|---|
Patients
The patients will receive a 500 ml fluid expansion over a standardized 10 minutes period
|
The fluid expansion will consist in a less than 10 min infusion of 500 milliliters of saline through a central venous catheter (jugular).
The duration of infusion will be controlled by an airbag pressurized at 300 mmHg.
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
---|---|---|
Change in cardiac output during fluid expansion
Tijdsspanne: 10 minutes
|
Difference between maximal cardiac output during fluid expansion and baseline
|
10 minutes
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
---|---|---|
Change in cardiac output after fluid expansion
Tijdsspanne: 2 hours
|
Change in cardiac output after fluid expansion
|
2 hours
|
Medewerkers en onderzoekers
Sponsor
Onderzoekers
- Hoofdonderzoeker: Martin Dres, MD, PhD, APHP
Publicaties en nuttige links
Studie record data
Bestudeer belangrijke data
Studie start (Werkelijk)
Primaire voltooiing (Werkelijk)
Studie voltooiing (Werkelijk)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Trefwoorden
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- ADOREPS
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .
Klinische onderzoeken op Saline Solution for Injection
-
Samsung Medical CenterIngetrokkenVloeiende responsiviteit | Neurologische ziekten of aandoeningen | Niet-invasieve cardiale outputbewaking | Grijze ZoneKorea, republiek van